|
|
Analysis on Influence of Sequential Chemoradiation and Concurrent Chemoradiation on the Occurrence of Radiation Pneumonia in Patients with Lung Cancer and Its Relationship with Lung Function |
REN Lili, SONG Yiling, CHEN Yun, et al |
People's Hospital of Fuyang City, Anhui Fuyang 236000, China |
|
|
Abstract Objective: To investigate the clinical efficacy of sequential chemotherapy and concurrent chemotherapy for lung cancer, the incidence of radiation pneumonitis (RP), and the influence on lung function. Methods: A total of 60 lung cancer patients admitted to our hospital from October 2017 to October 2020 were selected. According to the random number table, they were simply randomly divided into sequential groups and synchronous groups, with 30 cases in each group. The sequential group was treated with sequential radiotherapy and chemotherapy, and the synchronous group was treated with concurrent radiochemotherapy. The clinical efficacy, incidence of radiation pneumonia and changes in lung function index levels were compared between the two groups. Results: The total effective rate of the synchronous group (70.00% vs 46.67%) was higher than that of the sequential group, but the difference was not statistically significant (P>0.05). The overall clinical efficacy of the synchronous group was significantly better than that of the sequential group, and the difference was statistically significant (P<0.05). There was no statistically significant difference in the incidence of radiation pneumonia between the two groups (P>0.05). The rank sum test showed that the overall situation of radiation pneumonia in the sequential group was more serious than that in the synchronous group, and the difference was statistically significant (P<0.05). There was no statistically significant difference in lung function indexes between the two groups before treatment (all P>0.05); after treatment, FEV1[(1.69±0.18 vs 1.42±0.31)L], FVC[(3.02±0.27 vs 2.86) in the synchronous group ±0.32)L], FEV1/FVC[(56.09±4.86 vs 49.51±8.56)%] were significantly higher than the sequential group, and the difference was statistically significant (all P<0.05). Conclusion: Compared with sequential radiotherapy and chemotherapy, the overall curative effect of concurrent radiotherapy for lung cancer is better. It can reduce the degree of radiation pneumonitis and can significantly improve the level of lung function in patients.
|
|
|
|
|
[1] 潘元威,董军强,胡丽丽,等.螺旋CT灌注成像联合血清microRNA-20 a、microRNA-210水平对非小细胞肺癌同步放化疗预后的预测价值[J].郑州大学学报(医学版),2020,55(2):281~286. [2] 郑瑞锋,文海英,罗俊波,等.非小细胞肺癌Kras基因突变相关因素及其与一线同步放化疗疗效相关性研究[J].中华肿瘤防治杂志,2020,27(5):371~376. [3] 乌日罕,张荣繁.放射性肺损伤研究进展[J].癌症进展,2020,18(18):1840~1842. [4] 李明耀,项振飞,王巾帼,等.同步放化疗与序贯放化疗治疗局部晚期非小细胞肺癌的临床效果比较[J].中国基层医药,2019,26(7):868~872. [5] 吴挺,王蕙琴.同步放化疗联合巩固化疗与序贯放化疗对老年晚期非小细胞肺癌患者血清Chemerin水平及预后的影响比较[J].中国老年学杂志,2019,39(5):1079~1081. [6] 郑连喜,邓超,何平,等.重组人血管内皮抑制素注射液联合EP化疗、调强放疗对晚期非小细胞肺癌病人的影响[J].蚌埠医学院学报,2020,45(8):1013~1016,1019. [7] 饶建,张钦华,林秀欣,等.适形调强放疗联合靶向治疗肺癌脑转移的疗效及安全性分析[J].河北医学,2019,25(8):1380~1384. [8] 李梦瑶,刘盼,柯越海,等.放射性肺损伤中巨噬细胞作用机制的研究进展[J].浙江大学学报(医学版),2020,49(5):623~628. [9] 王纪煌,林萍,肖纪南.同步放化疗治疗局限期小细胞肺癌的疗效[J].中国肿瘤临床与康复,2019,26(3):320~323. [10] 冯淑娟,杨文龙.同步放化疗及序贯放化疗治疗非小细胞肺癌脑转移的疗效及生存质量分析[J].现代肿瘤医学,2018,26(4):527~529. |
|
|
|